| Verrucomicrobia subdivision 1| Verrucomicrobiaceae| Verrucomicrobiaceae Ward-Rainey et al. 1996 emend. Takeda et al. 2008| Verrucomicrobiaceae Ward-Rainey et al. 1996 emend. Yoon et al. 2008| Verrucosimicrobiaceae
Gut Microbiota: Some members of the family Verrucomicrobiaceae are known to inhabit the human gastrointestinal tract. Akkermansia muciniphila is a well-studied species within this family and is commonly found in the human colon. Research suggests that A. muciniphila may have beneficial effects on metabolic health and may be associated with a healthy gut microbiome. It has been linked to mucin degradation and has been studied in the context of obesity, diabetes, and other metabolic conditions.
Metabolic Health: Akkermansia muciniphila has been the focus of research due to its potential associations with metabolic health. Some studies suggest that increased abundance of A. muciniphila in the gut may be associated with a healthier metabolic profile, although more research is needed to fully understand the mechanisms and implications.
Mucin Degradation: A. muciniphila is known for its ability to degrade mucin, which is a glycoprotein present in the protective mucus layer lining the gut. This mucin degradation ability may contribute to its role in maintaining gut barrier function.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab Low and High are calculated using the formula that most labs use: Mean - 2 Standard Deviation to Mean + 2 Standard Deviation
Lab | KM Low | KM Percentile Low | KM High | KM Percentile High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High |
---|---|---|---|---|---|---|---|---|---|---|---|
* | 1 | 6.7 %ile | 398 | 86.7 %ile | 0 | 267 | 58 | 20 | 106.7 | 1 | 398 |
biomesight | 10 | 0 %ile | 15400 | 91 %ile | 0 | 94988 | 13735.7 | 610 | 41455.1 | 0 | 16630 |
thorne | 1 | 0 %ile | 51 | 100 %ile | 0 | 46 | 15.9 | 9 | 15.4 | 0 | 39 |
thryve | 13 | 8 %ile | 607 | 95 %ile | 0 | 48620 | 2034.3 | 25 | 23768.4 | 9 | 67 |
ubiome | 21 | 0 %ile | 54485 | 92 %ile | 0 | 135280 | 31110.2 | 9029 | 53148 | 0 | 73331 |
Low Boundary | High Boundary | Low Boundary %age | High Boundary %age | Lab Samples |
---|---|---|---|---|
0.88 | 5.4 | 0.0001 | 0.0005 | Thorne (20/80%ile) |
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
AmericanGut | 6.667 % | 0.04 % | % | 1.0 | 15 |
BiomeSight | 85.785 % | 1.353 % | 4.075 % | 2438.0 | 2842 |
BiomeSightRdp | 18.75 % | 0.002 % | 0.001 % | 6.0 | 32 |
CerbaLab | 66.667 % | 0.001 % | 0.001 % | 2.0 | 3 |
custom | 5.085 % | 0.008 % | 0.007 % | 3.0 | 59 |
es-xenogene | 3.448 % | 0.004 % | % | 1.0 | 29 |
Medivere | 42.857 % | 0.003 % | 0.001 % | 3.0 | 7 |
Thorne | 69.412 % | 0.001 % | 0.001 % | 59.0 | 85 |
Thryve | 17.754 % | 0.026 % | 0.275 % | 245.0 | 1380 |
uBiome | 27.525 % | 3.095 % | 5.322 % | 218.0 | 792 |
Click on Impact for information if high or low levels are causing the impact
Magnitude | Impact | Symptom |
---|
|
And display level must be raised above public.
Data comes from FoodMicrobionet. For the meaning of weight, see that site. The bacteria does not need to be alive to have an effect.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.